Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 May 21;8(1):56.
doi: 10.1038/s41394-022-00511-z.

Transient alteration of consciousness in spinal cord injury secondary to Baclofen use: a case report

Affiliations
Case Reports

Transient alteration of consciousness in spinal cord injury secondary to Baclofen use: a case report

Thomas John Pisano et al. Spinal Cord Ser Cases. .

Erratum in

Abstract

Introduction: Oral baclofen is commonly used for spasticity management, especially with neurogenic bladder in spinal cord injury (SCI). A less common side effect of baclofen is transient alterations of consciousness, which can easily be confused for altered mental status secondary to orthostatic hypotension in SCI.

Case presentation: A 43-year-old man with an acute SCI secondary to an aortic dissection was found to have episodes of confusion after titrating oral baclofen from 5 mg three times per day to 10 mg three times per day at an acute rehabilitation facility. Orthostatic hypotension was initially suspected as the cause of transient alterations of consciousness; however, he was never found to be hypotensive during these episodes. His confusion resolved several days after discontinuation of baclofen.

Discussion: Although, confusion and lightheadedness in SCI are commonly caused by orthostatic hypotension, it is important for physicians to be cognizant of baclofen's side effects, which increase in the setting of acute kidney injury (AKI). If an adverse effect is suspected, baclofen should be tapered while remaining observant for signs of baclofen withdrawal, which can be life-threatening. This case report is a reminder for clinicians to be aware of the uncommon adverse effects of baclofen when initiating therapy in SCI, especially in patients with AKI and neurogenic bladders.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Laboratory values during rehabilitation.
Values are plotted during inpatient rehabilitation. Upper and lower bounds of daily heart rate, systolic and diastolic blood pressure are plotted. Days with at least one episode of non-orthostatic, transient alteration of consciousness and separately days with orthostasis are shown. The patient was never found to be hypothermic (not shown).

Similar articles

Cited by

References

    1. Ghanavatian S, Derian A Baclofen. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020.
    1. Wuis EW, Dirks MJ, Termond EF, Vree TB, Van der Kleijn E. Plasma and urinary excretion kinetics of oral baclofen in healthy subjects. Eur J Clin Pharm. 1989;37:181–4. doi: 10.1007/BF00558228. - DOI - PubMed
    1. Simon N, Franchitto N, Rolland B. Pharmacokinetic studies of baclofen are not sufficient to establish an optimized dosage for management of alcohol disorder. Front Psychiatry. 2018;9:485. doi: 10.3389/fpsyt.2018.00485. - DOI - PMC - PubMed
    1. Knutsson E, Lindblom U, Mårtensson A. Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis. J Neurol Sci. 1974;23:473–84. doi: 10.1016/0022-510X(74)90163-4. - DOI - PubMed
    1. Wolf E, Kothari NR, Roberts JK, Sparks MA. Baclofen toxicity in kidney disease. Am J Kidney Dis. 2018;71:275–80. doi: 10.1053/j.ajkd.2017.07.005. - DOI - PubMed

Publication types

MeSH terms